3LEVEY AS, ECKARDT KU, TSUKAMOTO Y, et al. Defini- tion and classification of chronic kidney disease apposition statement from kidney disease: Improving Global Outcomes (KDIGO) [J~. Kidney Int,2005(6) ..2089-2100.
5Wang HY,Li JZ,Yu L,et al.Antifibrotic effect of the Chinese herbs,Astragalus mongholicus and Angelica sinensis,in a rat model of chronic puromycin aminonucleoside nephrosis[J].Life Sci,2004,74(13):1645-1658.
6Juni P,Sterchi R.Dieppe P.Systematic review of celecoxib for osteoarthritis and rheumatoid arthritis[J].BMJ 2003,326(7384):334.
7Tangiguchi Y,Yorika K,Masaki T,et al.Role of trans-forming growth factor-beta in glomerulonephritis[J].J Int Med Res.1997,25(1):71-80.
8Witko-Sarsat V,Friendlander M,Nguyen Khoa T,et al.Elevated circulating levels of interleukin-6 in patients with chronic renal failure[J].Immunol,1998,161:2524-2532.
9PANICHI V,MIGUORI M,DE PIETRO S,TACCOLA D,C-reactive protein and interleukin-6 levels aye related to renal function in pre--dialytic chronic renal failure[J].Nephren,2002,91(4):594-600.
